AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Amneal Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$19.36+0.18 (+0.94%)
Close on Oct 19, 2026
- Market cap
- $6.35B
- P/E (TTM)
- 39.5
- Dividend yield
- –
SEC filings
40 of Amneal Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 6, 2026 | Mar 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 2, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2025 | Aug 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2025 | Jul 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2025 | Jul 21, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 2, 2025 | May 2, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 6, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 1, 2025 | Mar 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 1, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 3, 2024 | May 3, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 2, 2024 | Mar 22, 2024 | SEC EDGAR |